ARTICLE | Clinical News
Egrifta tesamorelin regulatory update
July 11, 2011 7:00 AM UTC
Theratechnologies said Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) has filed an application to the Israeli Ministry of Health for tesamorelin to treat excess abdominal fat in HIV-infected patients...